Narrowing the localization of the region breakpoint in most frequent robertsonian translocations.
Jarmuz-Szymczak M, Janiszewska J, Szyfter K, Shaffer L;
Chromosome Res, 2014, 22 (4): 517-532.
Publikacje
Publikacje pracowników w ePub
Recurrence risks for different pregnancy outcomes and meiotic segregation analysis of spermatozoa in carriers of t(1;11)(p36.22;q12.2).
Midro AT, Panasiuk B, Stasiewicz-Jarocka B, Olszewska M, Wiland E, Myśliwiec M, Kurpisz M, Shaffer LG, Gajecka M;
J Hum Genet, 2014, 59 (12): 667-674.
Ten new ATM alterations in Polish patients with ataxia-telangiectasia.
Podralska MJ, Stembalska A, Ślęzak R, Lewandowicz-Uszyńska A, Pietrucha B, Kołtan S, Wigowska-Sowińska J, Pilch J, Mosor M, Ziółkowska-Suchanek I, Dzikiewicz-Krawczyk A, Słomski R;
Mol Genet Genomic Med, 2014, 2 (6): 504-511.
Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with ß-naphthoflavone
Brauze D, Fijalkiewicz K, Szaumkessel M, Kiwerska K, Bednarek K, Rydzanicz M, Richter J, Grenman R, Jarmuz-Szymczak M;
Toxicol Lett, 2014, 231 (1): 99-107.
The antispermal antibodies in different groups of infertile men [w j. ukraińskim].
Havrylyuk A, Chopyak V, Nakonechnyy Y, Kamieniczna M, Kurpisz M;
Andrology, 2014, 18 (3): 17-25.
Analiza DNA. Praktyka.
Słomski R;
Wyd. Uniwersytetu Przyrodniczego w Poznaniu, ISBN 978-83-7160-763-9: 1-304.
Double transgenic pigs with combined expression of human α-1,2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection.
Zeyland J, Woźniak A, Gawrońska B, Juzwa W, Jura J, Nowak A, Słomski R, Smorąg Z, Szalata M, Mazurek U, Lipiński D;
Archivum Immunologiae et Therapiae Experimentalis, 2014; 62 (5): 411-422.
Effect of growth hormone receptor gene disruption and PMA treatment on the expression of genes involved in primordial follicle activation in mice ovaries.
Schneider A, Zhi X, Bartke A, Kopchick JJ, Masternak MM;
Age, 2014, 36 (4): e9701.
Mutation in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues
Januszkiewicz-Lewandowska D, Rucka A, Kowala-Piaskowska A, Bereszyńska I, Mozer-Lisewska I, Zając-Spychała O, Wysocki J, Nowak J;
Acta Virol, 2014, 58 (2): 185-189.
CCDC151 mutations cause Primary Ciliary Dyskinesia by disruption of the outer dynein arm docking complex formation.
Hjeij R, Onoufriadis A, Watson CM, Slagle CE, Klena NT, Dougherty GW, Kurkowiak M, Loges NT, Diggle CP, Morante NF, Gabriel GC, Lemke KL, Li Y, Pennekamp P, Menchen T, Konert F, Marthin JK, Mans DA, Letteboer SJ, Werner C, Burgoyne T, Westermann C, Rutman A, Carr IM, O’Callaghan C, Moya E, Chung EM; UK10K Consortium, Sheridan E, Nielsen KG, Roepman R, Bartscherer K, Burdine RD, Lo CW, Omran H, Mitchison HM;
Am J Hum Genet, 2014, 95 (3): 257-274.